Clinical Genome Resource

What Clinical Genome Resource does

Clinical Genome Resource (ClinGen) is a US-based nonprofit research consortium founded in 2013 by the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health, to define the clinical relevance of genes and genomic variants for use in precision medicine and research. ClinGen operates a centralized, NIH-funded platform that supports expert-driven curation across four core domains: gene-disease validity, variant pathogenicity (using ACMG/AMP guidelines), clinical actionability, and dosage sensitivity, supplemented by somatic cancer variant curation, baseline literature annotation, and curation of submissions to NCBI's ClinVar database. The platform comprises a set of interconnected web interfaces and databases, including the Gene-Disease Validity Curation Interface, the ClinGen Evidence Repository, the Criteria Specification Registry (CSpec), the Actionability Knowledge Repository, the GenCC harmonization database, and the GenomeConnect patient portal, exposed to users through free public access, APIs, and downloadable data files.

The organization is governed by a Steering Committee and staffed through a community-led model involving more than 2,800 contributors across 77 countries and over 100 expert panels (Gene Curation Expert Panels and Variant Curation Expert Panels), supported by a network of Clinical Domain Working Groups and specialized committees covering pharmacogenomics, somatic cancer, copy number variants, HLA, low penetrance alleles, and data access. ClinGen's primary user groups are clinical genetic testing laboratories, clinical geneticists and genetic counselors, genomics researchers, and regulatory bodies, particularly the FDA, which has formally recognized ClinGen's frameworks. The consortium distributes its outputs through partnerships with NCBI ClinVar, CPIC, and PharmGKB, embedding ClinGen classifications directly into the variant interpretation workflows of clinical laboratories worldwide.

ClinGen's business model is that of a publicly funded research resource rather than a commercial enterprise. The organization is sustained by NHGRI grants, with NHGRI acting as primary sponsor; no commercial pricing is published and all databases, tools, and educational materials are provided free of charge. There are no disclosed venture capital or private equity investors, no subsidiaries, and no acquisition history. The structural setup is closer to a public-sector standards body than a venture-backed company, with moat sources rooted in regulatory recognition, accumulated curated data, ecosystem integration with ClinVar and other genomic reference resources, and the voluntary participation of specialized clinical and scientific experts.

Name

Clinical Genome Resource

Legal name

Clinical Genome Resource

Website

https://clinicalgenome.org

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Clinical Genome Resource is an NIH-funded research consortium founded in 2013 that provides standardized, expert-curated classifications of gene-disease validity, variant pathogenicity, clinical actionability, and dosage sensitivity to clinical laboratories, geneticists, researchers, and regulators worldwide.

Ownership category

akta.pro rank

Product category

Clinical Genomics Curation

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Molecular Tumor Boards & Clinical Interpretation Services (HLAAANAD)

akta.pro secondary industries

Multi-Omics Precision Medicine Platforms (genomics/proteomics/metabolomics) (HLAAANAF), Pharmacogenomics (PGx) Decision Support (HLAAANAB)

Keywords

• Clinical genomics curation
• Variant pathogenicity assessment
• Gene-disease validity
• Clinical actionability curation
• Dosage sensitivity curation

Headquarters

HQ city

Bethesda

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations

Revenue model

1. NIH Funding: ClinGen is funded by the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health. The organization operates as a research consortium rather than a commercial entity.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Core offering

ClinGen provides expert-curated clinical genomics knowledge through multiple curation activities (gene-disease validity, variant pathogenicity, clinical actionability, dosage sensitivity, somatic cancer variant curation, and baseline annotation) delivered via web-based databases, APIs, and curation interfaces to standardize genome interpretation for clinical medicine and research. The consortium operates more than 100 expert panels and engages over 2,800 contributors across 77 countries to produce consensus-driven, standardized clinical relevance for genes and variants.

Product overview

ClinGen is a centralized NIH-funded resource founded in 2013 by the National Human Genome Research Institute, involving over 2,800 contributors from 77 countries. The platform offers a suite of interconnected curation products: Gene-Disease Validity Curation and Variant Pathogenicity Curation form the core products for assessing whether genes cause disease and which variants are pathogenic; Clinical Actionability Curation and Dosage Sensitivity Curation address clinical utility and copy number effects; additional products include Somatic Cancer Variant Curation, Baseline Annotation for literature curation, and ClinGen's ClinVar curation work. These products are supported by specialized interfaces (Gene-Disease Validity Curation Interface, Actionability Knowledge Repository, ClinGen Evidence Repository, Criteria Specification Registry) and resources (GenCC Database, GenomeConnect patient portal, ClinGen Lab List, Variant Classification Guidance). The platform enables expert panels to develop disease-specific specifications and disseminate standardized genomic knowledge for precision medicine.

Differentiator

Problem solved

Functional benefit

Products and services

• Gene-Disease Validity Curation Expert-panel curation of the clinical validity of gene-disease associations, providing standardized evidence-based assessments used by clinical laboratories, clinicians, and researchers interpreting genomic findings.
• Variant Pathogenicity Curation Expert-panel curation of genetic variant classifications using standardized ACMG/AMP-based criteria to determine pathogenicity, delivered to clinical laboratories and clinicians interpreting variants.
• Clinical Actionability Curation Expert-panel curation of clinical actionability for gene-variant pairs, assessing whether interventions are available and effective for patients carrying specific genetic findings, intended for clinicians, laboratories, and guideline developers.
• Dosage Sensitivity Curation Expert-panel curation of dosage sensitivity for genes and genomic regions, evaluating haploinsufficiency and triplosensitivity to inform the interpretation of copy-number and structural variants.
• Somatic Cancer Variant Curation Expert-panel curation of somatic variants in cancer, applying standardized oncogenicity classification frameworks to support oncologists, cancer geneticists, and molecular tumor boards.
• GenomeConnect Patient Portal Patient-facing online portal that supports the GenomeConnect registry, enabling patients and families to contribute health and genomic data for clinical genomics research.
• GenCC Database

Quantifiable outcome

• Comprehensive curation of gene-disease validity relationships used globally for clinical decision support
• +1 more outcomes

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability2 records

Feature7 records

Partnerships

Four partnerships are on record, tiered core.

• ClinVar (NCBI)coreTechnology or IntegrationClinGen has a formal partnership with ClinVar, the NCBI database of genetic variants. Expert panels submit curated variant classifications to ClinVar, creating the primary integration point for clinical variant data. This partnership ensures ClinGen curations reach clinical laboratories worldwide.
• CPIC (Clinical Pharmacogenetics Implementation Consortium)coreStrategic or Co-development PartnerClinGen maintains a partnership with CPIC and PharmGKB for pharmacogenomics interpretation, combining expertise in gene-disease curation with pharmacogenomic variant interpretation.
• PharmGKBcoreStrategic or Co-development PartnerPartnership for pharmacogenomics data integration, linking ClinGen's gene curation work with drug-gene variant interpretation resources.
• FDA (Food and Drug Administration)coreStrategic or Co-development PartnerClinGen has received FDA recognition for its curation frameworks and variant classification guidelines, indicating regulatory acceptance of ClinGen standards for clinical genomics.

Scale indicators3 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• CPIC (Stanford / St. Jude Children's Research Hospital): CPIC provides peer-reviewed clinical guidelines for pharmacogenomic variant interpretation. Comparable to ClinGen for clinical actionability curation in the PGx space and a formal partner for joint curation activities.
• CIViC (Washington University in St. Louis): CIViC is an open-access, expert-curated platform for clinical interpretations of variants in cancer. Directly comparable as a peer curation platform integrated with ClinGen for somatic variant interpretation work.
• DECIPHER (Wellcome Sanger Institute): DECIPHER is a database of genomic variation and associated phenotypes in patients with rare conditions. Comparable to ClinGen for clinical genomic data curation supporting interpretation and rare disease diagnosis.
• COSMIC (Wellcome Sanger Institute): COSMIC is a comprehensive database of somatic mutations in human cancer, comparable to ClinGen for its somatic cancer variant curation - an area of overlapping coverage via ClinGen's Somatic Cancer Clinical Domain Working Group.
• LOVD (Leiden University Medical Center): LOVD provides locus-specific open variation databases used by clinical genetics labs globally. Comparable to ClinGen for variant-classification purposes and often used as a complementary resource alongside ClinGen's gene-level curations.
• ClinVar (NCBI/NIH): NCBI's ClinVar is the primary public database of genomic variant interpretations and the principal integration point for ClinGen-curated classifications. Most directly comparable to ClinGen as the dominant variant-interpretation database used by clinical laboratories worldwide.
• PharmGKB (Stanford University): PharmGKB curates knowledge about drug-gene-variant relationships for pharmacogenomics. Comparable to ClinGen for its curated approach to genomic variant interpretation in PGx, and a formal ClinGen partner with overlapping scope in that domain.

Broad incumbents

• gnomAD (Broad Institute): gnomAD provides population-level allele frequencies used by variant interpretation frameworks. Comparable to ClinGen as a reference resource feeding into clinical variant interpretation, though focused on population frequency data rather than curated pathogenicity.
• OMIM (McKusick-Nathans Institute, Johns Hopkins): OMIM is a comprehensive catalog of human genes and genetic phenotypes maintained at Johns Hopkins. Comparable to ClinGen in providing curated gene-disease knowledge, though broader and more phenotype-focused rather than variant-classification-focused.
• HGMD (QIAGEN): The Human Gene Mutation Database is a commercial database of human gene mutations maintained by QIAGEN. Comparable to ClinGen for variant and gene-disease curation, though commercialized and widely licensed by clinical labs alongside ClinGen classifications.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/ClinGenResource
• YouTubeyoutube.com/channel/UCsn4nEVUTpVQz70rClgMMsQ
• Facebookfacebook.com/ClinGenResource
• LinkedInlinkedin.com/company/clingen-resource

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Clinical Genome Resource